60
Views
13
CrossRef citations to date
0
Altmetric
Review

Lyme neuroborreliosis in children

&
Pages 455-463 | Published online: 10 Jan 2014

References

  • Pachner AR, Steiner I. Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol.6, 544–552 (2007).
  • Stanek G, Strle F. Lyme borreliosis. Lancet362, 1639–1647 (2003).
  • Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme disease United States 1992–2006. MMWR Surveill. Summ.57, 1–9 (2008).
  • Jones KL, Muellegger RR, Means TK et al. Higher mRNA levels of chemokines and cytokines associated with macrophage activation in erythema migrans skin lesions in patients from the United States than in patients from Austria with Lyme borreliosis. Clin. Infect. Dis.46, 85–92 (2008).
  • Strle K, Drouin EE, Shen S et al.Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii and Borrelia garinii. J. Infect. Dis.200, 1963–1943 (2009).
  • Rupprecht TA, Koedel U, Fingerle V, Pfister HW. The pathogenesis of Lyme neuroborreliosis: from infection to inflammation. Mol. Med.14, 205–212 (2008).
  • Christen HJ, Hanefeld F, Eiffert H, Thomssen R. Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborelliosis. Acta Paediatr. Suppl.386, 1–75 (1993).
  • Strle F, Ruzic-Sabljic E, Cimperman J, Lotric-Furlan S, Maraspin V. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin. Infect. Dis.43, 704–710 (2006).
  • Nachman SA, Pontrelli L. Central nervous system Lyme disease. Semin. Pediatr. Infect. Dis.14, 123–130 (2003).
  • Tveitnes D, Oymar K, Natas O. Acute nerve facial palsy in children: how often is it Lyme borreliosis? Scand. J. Infect. Dis.39, 425–431 (2007).
  • Cook SP, Macartney KK, Rose CD, Hunt PG, Eppes SC, Reilly JS. Lyme disease and seventh nerve paralysis in children. Am. J. Otolaryngol.18, 320–323 (1997).
  • Nigrovic LE, Thompson AD, Fine AM, Kimia A. Clinical predictors of Lyme disease among children with a peripheral facial palsy at an emergency department in a Lyme endemic area. Pediatrics122, e1080–e1085 (2008).
  • Oymar K, Tveitnes D. Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe. Scand. J. Infect. Dis.41, 88–94 (2009).
  • Skogman BH, Croner S, Nordwall M, Eknefelt M, Ernerudh J, Forsberg P. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. Pediatr. Infect. Dis. J.27, 1089–1094 (2008).
  • Belman AL, Reynolds L, Preston T, Postels D, Grimson R, Coyle PK. Cerebrospinal fluid findings in children with Lyme disease-associated facial nerve palsy. Arch. Pediatr. Adolesc. Med.151, 1224–1228 (1997).
  • Wormser GP, Dattwyler RJ, Shapiro ED et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocyic anaplasmosis, and babesiosis: clinical practice guidelines by the infectious diseases society of America. Clin. Infect. Dis.43, 1089–1134 (2006).
  • Eppes SC, Nelson DK, Lewis LL, Klein JD. Characterization of Lyme meningitis and comparison with viral meningitis in children. Pediatrics103, 957–960 (1999).
  • Tuerlinckx D, Bodart E, Garrino MG, de Bilderling G. Clinical data and cerebrospinal fluid findings in Lyme meningitis versus aseptic meningitis. Eur. J. Pediatr.162, 150–153 (2003).
  • Shah SS, Zaoutis TE, Turnquist J, Hodinka RL, Coffin SE. Early differentiation of Lyme from enteroviral meningitis. Pediatr. Infect. Dis. J.24, 542–545 (2005).
  • Avery RA, Frank G, Glutting J, Eppes SC. Prediction of Lyme meningitis in children from a Lyme disease-endemic region: a logistic-regression model using history, physical, and laboratory findings. Pediatrics117, e1–e7 (2006).
  • Tuerlinckx D, Bodart E, Jamart J, Glupczynski Y. Prediction of Lyme meningitis based on a logistic regression model using clinical and cerebrospinal fluid analysis: a European study. Pediatr. Infect. Dis. J.28, 394–397 (2009).
  • Garro AC, Rutman M, Simonsen K, Jaeger JL, Chapin K, Lockhart G. Prospective validation of a clinical prediction model for Lyme meningitis in children. Pediatrics123, e829–e834 (2009).
  • Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H. 5-y follow-up study of patients with neuroborrelisosis. Scand. J. Infect. Dis.34, 421–425 (2002).
  • Adams WV, Rose CD, Eppes SC, Klein JD. Long-term cognitive effects of Lyme disease in children. Appl. Neuropsychol.6, 39–45 (1999).
  • Seltzer E, Gerber MA, Cartter ML, Freudigman K, Shapiro ED. Long-term outcomes of persons with Lyme disease. JAMA283, 609–616 (2000).
  • Vazquez M, Sparrow SS, Shapiro ED. Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease. Pediatrics112, e93–e97 (2003).
  • Hoppa E, Bachur R. Lyme disease update. Curr. Opin. Pediatr.19, 275–280 (2007).
  • Skogman BH, Croner S, Odkvist L. Acute facial palsy in children-a-2-year follow-up study with focus on Lyme neuroborreliosis. Int. J. Pediatr. Otorhinolaryngol.67, 597–602 (2003).
  • Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev.18, 484–509 (2005).
  • Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia brugdorferi-specific immunoglobulin G, A, and M. Ann. Neurol.30, 197–205 (1991).
  • Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol. Med. Microbiol.49, 13–21 (2007).
  • Tveitnes D, Oymar K, Nat O. Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms. Scand. J. Infect. Dis.41, 355–362 (2009).
  • Brouqui P, Bacellar F, Baranton G et al. Guidelines for the diagnosis of tick-borne bacterial disease in Europe. Clin. Microbiol. Infect.10, 1108–1132 (2004).
  • Blanc F, Jaulhac B, Fleury M et al. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology69, 953–958 (2007).
  • Bennet R, Lindgren V, Zweygberg W. Borrelia antibodies in children evaluated for Lyme neuroborreliosis Infection36, 463–466 (2008).
  • Ljostad U, Skarpaas T, Mygland A. Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur. J. Neurol.14, 873–876 (2007).
  • Liang FT, Aberer E, Cinco M et al. Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia brurgdorferi SL. J. Infect. Dis.182, 1455–1462 (2000).
  • Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J. Clin. Microbiol.37, 3990–3996 (1999).
  • Bacon RM, Biggerstaff BJ, Schriefer ME et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J. Infect. Dis.187, 1187–1199 (2003).
  • Mogilyansky E, Loa CC, Adelson ME, Mordechai E, Tilton RC. Comparison of western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease. Clin. Diagn. Lab. Immunol.11, 924–929 (2004).
  • Steere AC, McHugh G, Damle N, Sikand V. Prospective study of serologic tests for Lyme disease. Clin. Infect. Dis.47, 188–195 (2008).
  • Smismans A, Goossens VJ, Nulens E, Bruggeman CA. Comparison of five different immunoassays for the detection of Borrelia burgdorferi IgM and IgG antibodies. Clin. Microbiol. Infect.12, 648–655 (2006).
  • Jansson C, Carlsson SA, Granlund H, Wahlberg P, Nyman D. Analysis of Borrelia burgdorferi IgG antibodies with a combination of IgG ELISA and VIsE C6 peptide ELISA. Clin. Microbiol. Infect.11, 147–150 (2005).
  • Skarpaas T, Ljostad U, Sobye M, Mygland A. Sensitivity and specificity of a commercial C6 peptide enzyme immuno assay in diagnosis of acute Lyme neuroborrelisosis. Eur. J. Clin. Microbiol. Infect. Dis.26, 675–677 (2007).
  • Sillanpää H, Lahdenne P, Sarvas H et al. Immune responses to borrelial VlsE IR6 peptide variants. Int. J. Med. Microbiol.297, 45–52 (2007).
  • Tjernberg I, Schön T, Ernerudh J, Carlsson Wistedt A, Forsberg P, Eliasson I. C6-peptide serology as diagnostic tool in neuroborreliosis. APMIS116, 393–399 (2008).
  • Halperin JJ, Shapiro ED, Logigian E et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology69, 91–102 (2007).
  • Thorstrand C, Belfrage E, Bennet R, Malmborg P, Eriksson M. Successful treatment of neuroborreliosis with ten day regimens. Pediatr. Infect. Dis. J.21, 1142–1145 (2002).
  • Ljostad U, Skogvoll E, Eikeland R et al. Oral doxycycline versus ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol.7, 690–695 (2008).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.